Marker Therapeutics, Inc. (MRKR): Price and Financial Metrics
MRKR Price/Volume Stats
| Current price | $2.46 | 52-week high | $5.99 |
| Prev. close | $2.66 | 52-week low | $2.44 |
| Day low | $2.46 | Volume | 48,700 |
| Day high | $2.73 | Avg. volume | 41,264 |
| 50-day MA | $3.45 | Dividend yield | N/A |
| 200-day MA | $3.85 | Market Cap | 26.34M |
MRKR Stock Price Chart Interactive Chart >
Marker Therapeutics, Inc. (MRKR) Company Bio
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications.
MRKR Price Returns
| 1-mo | -35.26% |
| 3-mo | -45.45% |
| 6-mo | -53.50% |
| 1-year | -46.05% |
| 3-year | -59.00% |
| 5-year | -92.14% |
| YTD | -20.90% |
| 2024 | -43.45% |
| 2023 | 106.84% |
| 2022 | -72.02% |
| 2021 | -34.47% |
| 2020 | -49.65% |
Loading social stream, please wait...